Skip to main content
Top
Published in: Diabetologia 7/2006

01-07-2006 | Article

Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity

Authors: A. Mairal, D. Langin, P. Arner, J. Hoffstedt

Published in: Diabetologia | Issue 7/2006

Login to get access

Abstract

Aims/hypothesis

The recent identification of murine adipose triglyceride lipase (ATGL, now known as patatin-like phospholipase domain containing 2 [PNPLA2]), gene product of Pnpla2, has questioned the unique role of hormone sensitive lipase (HSL, now known as LIPE), gene product of Lipe, in fat cell lipolysis. Here, we investigated human ATGL and HSL adipose tissue gene expression and in vitro lipase activity.

Subjects, materials and methods

Levels of mRNA in adipose tissue from healthy obese and non-obese subjects were measured and lipase activity and adipocyte lipolytic capacity determined. HSL and ATGL cDNAs were transfected into Cos-7 cells and the relative tri- and diglyceride hydrolase activities were measured.

Results

Obesity was associated with a decreased subcutaneous and increased omental adipose tissue level of HSL mRNA. Subcutaneous HSL mRNA content was normalised upon weight reduction. In contrast, ATGL mRNA levels were unaffected by obesity and weight reduction. A high adipose tissue lipase activity was associated with increased maximal lipolysis and increased HSL, but not with ATGL mRNA levels. The in vitro triglyceride hydrolase activity of HSL was markedly higher than that of ATGL and contrary to HSL, ATGL was devoid of diglyceride hydrolase activity. The use of a selective HSL-inhibitor resulted in complete inhibition of HSL-mediated tri- and diglyceride hydrolase activity. The pH profile of human white adipose tissue triolein hydrolase activity was identical to that of HSL but differed from the ATGL profile.

Conclusions/interpretation

HSL, but not ATGL gene expression shows a regulation according to obesity status and is associated with increased adipose tissue lipase activity. Moreover, HSL has a higher capacity than ATGL to hydrolyse triglycerides in vitro.
Literature
1.
go back to reference Large V, Arner P (1998) Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24:409–418PubMed Large V, Arner P (1998) Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24:409–418PubMed
2.
go back to reference Holm C (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31:1120–1124PubMedCrossRef Holm C (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31:1120–1124PubMedCrossRef
3.
go back to reference Langin D, Lucas S, Lafontan M (2000) Millennium fat-cell lipolysis reveals unsuspected novel tracks. Horm Metab Res 32:443–452PubMedCrossRef Langin D, Lucas S, Lafontan M (2000) Millennium fat-cell lipolysis reveals unsuspected novel tracks. Horm Metab Res 32:443–452PubMedCrossRef
4.
go back to reference Osuga J, Ishibashi S, Oka T et al (2000) Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 97:787–792PubMedCrossRef Osuga J, Ishibashi S, Oka T et al (2000) Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 97:787–792PubMedCrossRef
5.
go back to reference Wang SP, Laurin N, Himms-Hagen J et al (2001) The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res 9:119–128PubMed Wang SP, Laurin N, Himms-Hagen J et al (2001) The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res 9:119–128PubMed
6.
go back to reference Okazaki H, Osuga J, Tamura Y et al (2002) Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. Diabetes 51:3368–3375PubMedCrossRef Okazaki H, Osuga J, Tamura Y et al (2002) Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. Diabetes 51:3368–3375PubMedCrossRef
7.
go back to reference Haemmerle G, Zimmermann R, Hayn M et al (2002) Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 277:4806–4815PubMedCrossRef Haemmerle G, Zimmermann R, Hayn M et al (2002) Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 277:4806–4815PubMedCrossRef
8.
go back to reference Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS (2204) Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 279:47066–47075CrossRef Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS (2204) Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 279:47066–47075CrossRef
9.
go back to reference Zimmermann R, Strauss JG, Haemmerle G et al (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383–1386PubMedCrossRef Zimmermann R, Strauss JG, Haemmerle G et al (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383–1386PubMedCrossRef
10.
go back to reference Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW (2004) Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279:48968–48975PubMedCrossRef Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW (2004) Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279:48968–48975PubMedCrossRef
11.
go back to reference Langin D, Dicker A, Tavernier G et al (2005) Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54:3190–3197PubMedCrossRef Langin D, Dicker A, Tavernier G et al (2005) Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54:3190–3197PubMedCrossRef
12.
go back to reference Kolaczynski JW, Morales LM, Moore JH et al (1994) A new technique for biopsy of human abdominal fat under local anaesthesia with lidocaine. Int J Obes Relat Metab Disord 18:161–166PubMed Kolaczynski JW, Morales LM, Moore JH et al (1994) A new technique for biopsy of human abdominal fat under local anaesthesia with lidocaine. Int J Obes Relat Metab Disord 18:161–166PubMed
13.
go back to reference Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P (2002) Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 51:1601–1608PubMedCrossRef Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P (2002) Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 51:1601–1608PubMedCrossRef
14.
go back to reference Holm C, Olivecrona G, Ottosson M (2001) Assays of lipolytic enzymes. In: Ailhaud G (editor) Methods in molecular biology. Humana, Totowa, pp 97–119 Holm C, Olivecrona G, Ottosson M (2001) Assays of lipolytic enzymes. In: Ailhaud G (editor) Methods in molecular biology. Humana, Totowa, pp 97–119
15.
go back to reference Lowe DB, Magnuson S, Qi N et al (2004) In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase. Bioorg Med Chem Lett 14:3155–3159PubMedCrossRef Lowe DB, Magnuson S, Qi N et al (2004) In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase. Bioorg Med Chem Lett 14:3155–3159PubMedCrossRef
16.
go back to reference Ausubel FM, Brent R, Kingston RE et al (1996) Current protocols in molecular biology. New York, Wiley Ausubel FM, Brent R, Kingston RE et al (1996) Current protocols in molecular biology. New York, Wiley
17.
go back to reference Fredrikson G, Strålfors P, Nilsson NÖ, Belfrage P (1981) Hormone-sensitive lipase of rat adipose tissue. Purification and some properties. J Biol Chem 256:6311–6320PubMed Fredrikson G, Strålfors P, Nilsson NÖ, Belfrage P (1981) Hormone-sensitive lipase of rat adipose tissue. Purification and some properties. J Biol Chem 256:6311–6320PubMed
18.
go back to reference Large V, Reynisdottir S, Langin D et al (1999) Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 40:2059–2066PubMed Large V, Reynisdottir S, Langin D et al (1999) Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 40:2059–2066PubMed
19.
go back to reference Lonnqvist F, Thome A, Nilsell K et al (1995) A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 95:1109–1116PubMedCrossRef Lonnqvist F, Thome A, Nilsell K et al (1995) A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 95:1109–1116PubMedCrossRef
20.
go back to reference Large V, Arner P, Reynisdottir S et al (1998) Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. J Lipid Res 39:1688–1695PubMed Large V, Arner P, Reynisdottir S et al (1998) Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. J Lipid Res 39:1688–1695PubMed
21.
go back to reference Raclot T, Holm C, Langin D (2001) A role for hormone-sensitive lipase in the selective mobilization of adipose tissue fatty acids. Biochim Biophys Acta 1532:88–96PubMed Raclot T, Holm C, Langin D (2001) A role for hormone-sensitive lipase in the selective mobilization of adipose tissue fatty acids. Biochim Biophys Acta 1532:88–96PubMed
22.
go back to reference Tornqvist H, Belfrage P (1976) Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J Biol Chem 251:813–819PubMed Tornqvist H, Belfrage P (1976) Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J Biol Chem 251:813–819PubMed
23.
go back to reference Bengtsson G, Olivecrona T (1982) On the pH dependency of lipoprotein lipase activity. Biochim Biophys Acta 712:196–199PubMed Bengtsson G, Olivecrona T (1982) On the pH dependency of lipoprotein lipase activity. Biochim Biophys Acta 712:196–199PubMed
24.
go back to reference Fredrikson G, Tornqvist H, Belfrage P (1986) Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim Biophys Acta 876:288–293PubMed Fredrikson G, Tornqvist H, Belfrage P (1986) Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim Biophys Acta 876:288–293PubMed
25.
go back to reference Sengenes C, Zakaroff-Girard A, Moulin A et al (2002) Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 283:R257–265PubMed Sengenes C, Zakaroff-Girard A, Moulin A et al (2002) Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 283:R257–265PubMed
Metadata
Title
Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity
Authors
A. Mairal
D. Langin
P. Arner
J. Hoffstedt
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0272-x

Other articles of this Issue 7/2006

Diabetologia 7/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.